Which psychiatric medications cause weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Psychiatric Medications That Cause Weight Gain

Among psychiatric medications, antipsychotics carry the highest risk for weight gain, with olanzapine and clozapine causing the most substantial increases (3.8-16.2 kg and 0.9-9.5 kg respectively), followed by risperidone and quetiapine; among antidepressants, paroxetine, amitriptyline, and mirtazapine cause the most weight gain (1.5-1.8 kg), while mood stabilizers valproic acid and lithium also significantly increase weight. 1, 2

Antipsychotics (Highest Risk Category)

The atypical antipsychotics demonstrate the most pronounced weight gain potential through their effects on histamine H1 receptors, anticholinergic pathways, and serotonin 2C antagonism 1:

High-Risk Antipsychotics:

  • Olanzapine: 3.8-16.2 kg weight gain; 30% of patients gain >7% baseline weight; associated with increased triglycerides and 37% increased diabetes incidence 1
  • Clozapine: 0.9-9.5 kg weight gain; continues for up to 46 months with metabolic complications including diabetes 1
  • Risperidone: 1.9-7.2 kg weight gain; 14% of patients gain >7% baseline weight 1
  • Quetiapine: 2.3-6.1 kg weight gain; 16% of patients gain >7% baseline weight 1

Lower-Risk Antipsychotics:

  • Ziprasidone: Only 1.0 kg gain (7% of patients gain >7% baseline weight); switching from olanzapine to ziprasidone results in weight loss and improved lipid/glucose profiles 1, 2
  • Aripiprazole: 0-4.4 kg weight gain 1
  • Lurasidone: Most weight-neutral option 2

Clinical Pitfall: The weight gain with clozapine and olanzapine is not just cosmetic—it carries a 37% increased risk of developing type 2 diabetes over 5 years 1.

Antidepressants (Moderate Risk Category)

High-Risk Antidepressants:

  • Paroxetine: Greatest long-term weight gain among SSRIs 1, 2, 1
  • Amitriptyline: 1.8 kg weight gain; most potent among tricyclics 1
  • Mirtazapine: 1.5 kg weight gain 1
  • Nortriptyline: Associated with weight gain 1

Weight-Neutral or Weight-Loss Antidepressants:

  • Bupropion: 1.3 kg weight loss; only antidepressant that consistently causes weight loss 1, 2
  • Fluoxetine: 1.3 kg weight loss acutely (4-12 weeks), then weight-neutral long-term 1
  • Sertraline: Weight loss acutely, weight-neutral long-term 1
  • Citalopram/Escitalopram: No significant effect 1
  • Imipramine: Weight-neutral 1

Slight Weight Gain:

  • Venlafaxine and Duloxetine: Slight long-term weight increase, though data are limited 1

Important Note: Lithium and MAO inhibitors are also associated with weight gain 2.

Mood Stabilizers/Anticonvulsants (Variable Risk)

High-Risk Agents:

  • Valproic Acid: 47% of patients gain >10% baseline weight; 24% gain 5-10% 1
  • Gabapentin: 2.2 kg after 1.5 months; 57% gain >5% baseline weight, 23% gain >10% 1
  • Pregabalin: Associated with weight gain 1
  • Carbamazepine: Weight gain, though less than valproic acid or gabapentin 1
  • Vigabatrin: Associated with weight gain 1

Weight-Neutral Agents:

  • Lamotrigine: No significant weight effect 1
  • Levetiracetam: Weight-neutral 1
  • Phenytoin: Weight-neutral 1

Weight-Loss Agents:

  • Topiramate: Causes weight loss 1
  • Zonisamide: Causes weight loss 1
  • Felbamate: Causes weight loss 1

Clinical Decision Algorithm

When prescribing psychiatric medications to patients concerned about weight:

  1. For psychosis/bipolar disorder: Prioritize ziprasidone, lurasidone, or aripiprazole over olanzapine/clozapine 1, 2

  2. For depression: Choose bupropion, fluoxetine, or sertraline over paroxetine, amitriptyline, or mirtazapine 1

  3. For seizures/mood stabilization: Select lamotrigine, levetiracetam, or phenytoin over valproic acid or gabapentin 1

  4. If patient gains weight on current medication: Consider switching from high-risk to low-risk agent within the same class—this typically reverses weight gain 1, 2

Critical Caveat: Weight gain risk must be balanced against psychiatric efficacy. For example, bupropion is activating and inappropriate for patients with anxiety or bipolar disorder 2. The Endocrine Society recommends shared decision-making with quantitative weight estimates provided to patients 1.

Monitoring Essential: Regular weight checks are critical, as weight gain often predicts metabolic complications including diabetes, particularly with olanzapine and clozapine 1.

References

Guideline

pharmacological management of obesity: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Guideline

practical use of pharmacotherapy for obesity.

Gastroenterology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.